Professor Jorgen Vestbo DrMedSci, FRCP

2011

• Afzelius, P., Bazeghi, N., Bie, P., Bendtsen, F., Vestbo, J. & Møller, S (2011). Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension. Liver Int, 31(9), 1381-7. eScholarID:137970 | PMID:21745317 | DOI:10.1111/j.1478-3231.2011.02576.x
• Agustí, A. & Vestbo, J (2011). Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 184(5), 507-13. eScholarID:137972 | PMID:21680951 | DOI:10.1164/rccm.201103-0405PP
• Al-Shair, K., Kolsum, U., Dockry, R., Morris, J., Singh, D. & Vestbo, J (2011). Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res, 12(1), 3. eScholarID:104979 | PMID:21208443 | DOI:10.1186/1465-9921-12-3
• Bakke, P., Zhu, G., Gulsvik, A., Kong, X., Agusti, A., Calverley, P., Donner, C., Levy, R., Make, B., Paré, P., Rennard, S., Vestbo, J., Wouters, E., Anderson, W., Lomas, D., Silverman, E. & Pillai, S (2011). Candidate genes for COPD in two large data sets. Eur Respir J, 37(2), 255-63. eScholarID:137965 | PMID:20562129 | DOI:10.1183/09031936.00091709
• Bazeghi, N., Gerds, T., Budtz-Jørgensen, E., Hove, J. & Vestbo, J (2011). Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD. Respir Med, 105(9), 1338-44. eScholarID:137975 | PMID:21530214 | DOI:10.1016/j.rmed.2011.03.015
• Castaldi, P., Demeo, D., Hersh, C., Lomas, D., Soerheim, I., Gulsvik, A., Bakke, P., Rennard, S., Pare, P., Vestbo, J., , , , & Silverman, E (2011). Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax, 66(10), 903-9. eScholarID:137979 | PMID:21163806 | DOI:10.1136/thx.2010.146118
• Celli, B., Vestbo, J., Jenkins, C., Jones, P., Ferguson, G., Calverley, P., Yates, J., Anderson, J., Willits, L., Wise, R. & . (2011). Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med, 183(3), 317-22. eScholarID:137987 | PMID:20813884 | DOI:10.1164/rccm.201004-0665OC
• Cho, M., Castaldi, P., Wan, E., Siedlinski, M., Hersh, C., Demeo, D., Himes, B., Sylvia, J., Klanderman, B., Ziniti, J., Lange, C., Litonjua, A., Sparrow, D., Regan, E., Make, B., Hokanson, J., Murray, T., Hetmanski, J., Pillai, S., Kong, X., Anderson, W., Tal-Singer, R., Lomas, D., Coxson, H., Edwards, L., Macnee, W., Vestbo, J., Yates, J., Agusti, A., Calverley, P., Celli, B., Crim, C., Rennard, S., Wouters, E., Bakke, P., Gulsvik, A., Crapo, J., Beaty, T., Silverman, E. & . (2011). A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet, eScholarID:137961 | PMID:22080838 | DOI:10.1093/hmg/ddr524
• Dahl, M., Vestbo, J., Zacho, J., Lange, P., Tybjærg-Hansen, A. & Nordestgaard, B (2011). C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax, 66(3), 197-204. eScholarID:137963 | PMID:21059738 | DOI:10.1136/thx.2009.131193
• Fabricius, P., Løkke, A., Marott, J., Vestbo, J. & Lange, P (2011). Prevalence of COPD in Copenhagen. Respir Med, 105(3), 410-7. eScholarID:137984 | PMID:20952174 | DOI:10.1016/j.rmed.2010.09.019
• Hanania, N., Müllerova, H., Locantore, N., Vestbo, J., Watkins, M., Wouters, E., Rennard, S., Sharafkhaneh, A. & . (2011). Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med, 183(5), 604-11. eScholarID:137973 | PMID:20889909 | DOI:10.1164/rccm.201003-0472OC
• Hoogendoorn, M., Hoogenveen, R., Rutten-van Mölken, M., Vestbo, J. & Feenstra, T (2011). Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J, 37(3), 508-15. eScholarID:137966 | PMID:20595157 | DOI:10.1183/09031936.00043710
• Janner, J., Godtfredsen, N., Ladelund, S., Vestbo, J. & Prescott, E (2011). The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J Hum Hypertens, eScholarID:137989 | PMID:21654851 | DOI:10.1038/jhh.2011.59
• Jenkins, C., Celli, B., Anderson, J., Ferguson, G., Jones, P., Vestbo, J., Yates, J. & Calverley, P (2011). Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J, eScholarID:137986 | PMID:21737561 | DOI:10.1183/09031936.00194610
• Jones, P., Anderson, J., Calverley, P., Celli, B., Ferguson, G., Jenkins, C., Yates, J., Vestbo, J., Spencer, M. & . (2011). Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res, 12, 71. eScholarID:137976 | PMID:21627828 | DOI:10.1186/1465-9921-12-71
• Rennard, S. & Vestbo, J (2011). Republished editorial: Hypothesis: in COPD, a pound of cure may be better than an ounce of prevention. Postgrad Med J, 87(1034), 793-4. eScholarID:137985 | PMID:22121250 | DOI:10.1136/pgmj.2010.151498rep
• Silverman, et al (2011). Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD, 8(2), 121-35. eScholarID:137982 | PMID:21495840 | DOI:10.3109/15412555.2011.558864
• Spruit, M., Polkey, M., Celli, B., Edwards, L., Watkins, M., Pinto-Plata, V., Vestbo, J., Calverley, P., Tal-Singer, R., Agusti, A., Coxson, H., Lomas, D., Macnee, W., Rennard, S., Silverman, E., Crim, C., Yates, J., Wouters, E. & . (2011). Predicting Outcomes from 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease. J Am Med Dir Assoc, eScholarID:137983 | PMID:21778120 | DOI:10.1016/j.jamda.2011.06.009
• Vestbo, J., Anderson, J., Calverley, P., Celli, B., Ferguson, G., Jenkins, C., Yates, J. & Jones, P (2011). Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study. Clin Respir J, 5(1), 44-9. eScholarID:104977 | PMID:21159140 | DOI:10.1111/j.1752-699X.2010.00198.x
• Vestbo, J., Edwards, L., Scanlon, P., Yates, J., Agusti, A., Bakke, P., Calverley, P., Celli, B., Coxson, H., Crim, C., Lomas, D., MacNee, W., Miller, B., Silverman, E., Tal-Singer, R., Wouters, E., Rennard, S. & . (2011). Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med, 365(13), 1184-92. eScholarID:137969 | PMID:21991892 | DOI:10.1056/NEJMoa1105482
• Yohannes, A., Willgoss, T. & Vestbo, J (2011). Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care, 56(4), 477-87. eScholarID:137991 | PMID:21255503 | DOI:10.4187/respcare.00852

2010

• Agusti, A., Calverley, P., Celli, B., Coxson, H., Edwards, L., Lomas, D., MacNee, W., Miller, B., Rennard, S., Silverman, E., Tal-Singer, R., Wouters, E., Yates, J. & Vestbo, J (2010). Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res, 11, 122. eScholarID:98675 | PMID:20831787 | DOI:10.1186/1465-9921-11-122
• Bakke, P., Zhu, G., Gulsvik, A., Kong, X., Agusti, A., Calverley, P., Donner, C., Levy, R., Make, B., Paré, P., Rennard, S., Vestbo, J., Wouters, E., Anderson, W., Lomas, D., Silverman, E. & Pillai, S (2010). Candidate genes for chronic obstructive pulmonary disease in two large data sets. Eur Respir J, eScholarID:98670 | PMID:20562129 | DOI:10.1183/09031936.00091709
• Briggs A, Glick H, Lozano-Ortega G, Spencer M, Calverley P, Jones P, Vestbo J. (2010). Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. European Respiratory Journal, 35, 532-539. eScholarID:78081 | DOI:10.1183/09031936.00153108
• Calverley, P., Anderson, J., Celli, B., Ferguson, G., Jenkins, C., Jones, P., Crim, C., Willits, L., Yates, J. & Vestbo, J (2010). Cardiovascular events in patients with COPD: TORCH study results. Thorax, 65(8), 719-25. eScholarID:98673 | PMID:20685748 | DOI:10.1136/thx.2010.136077
• Celli, B., Vestbo, J., Jenkins, C., Jones, P., Ferguson, G., Calverley, P., Yates, J., Anderson, J., Willits, L. & Wise, R (2010). Gender Differences in Mortality and Clinical Expressions of Patients with COPD: The TORCH Experience. Am J Respir Crit Care Med, eScholarID:98678 | PMID:20813884 | DOI:10.1164/rccm.201004-0665OC
• Dahl, M., Vestbo, J., Zacho, J., Lange, P., Tybjærg-Hansen, A. & Nordestgaard, B (2010). C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax, eScholarID:98671 | PMID:21059738 | DOI:10.1136/thx.2009.131193
• Eriksen, N. & Vestbo, J (2010). Management and survival of patients admitted with an exacerbation of COPD: comparison of two Danish patient cohorts. Clin Respir J, 4(4), 208-14. eScholarID:98680 | PMID:20887343 | DOI:10.1111/j.1752-699X.2009.00177.x
• Fabricius, P., Løkke, A., Marott, J., Vestbo, J. & Lange, P (2010). Prevalence of COPD in Copenhagen. Respir Med, eScholarID:98684 | PMID:20952174 | DOI:10.1016/j.rmed.2010.09.019
• Han, M., Agusti, A., Calverley, P., Celli, B., Criner, G., Curtis, J., Fabbri, L., Goldin, J., Jones, P., Macnee, W., Make, B., Rabe, K., Rennard, S., Sciurba, F., Silverman, E., Vestbo, J., Washko, G., Wouters, E. & Martinez, F (2010). Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med, 182(5), 598-604. eScholarID:98676 | PMID:20522794 | DOI:10.1164/rccm.200912-1843CC
• Hanania, N., Müllerova, H., Locantore, N., Vestbo, J., Watkins, M., Wouters, E., Rennard, S. & Sharafkhaneh, A (2010). Determinants of Depression in the ECLIPSE COPD Cohort. Am J Respir Crit Care Med, eScholarID:98677 | PMID:20889909 | DOI:10.1164/rccm.201003-0472OC
• Hersh, C., Pillai, S., Zhu, G., Lomas, D., Bakke, P., Gulsvik, A., DeMeo, D., Klanderman, B., Lazarus, R., Litonjua, A., Sparrow, D., Reilly, J., Agusti, A., Calverley, P., Donner, C., Levy, R., Make, B., Paré, P., Rennard, S., Vestbo, J., Wouters, E., Scholand, M., Coon, H., Hoidal, J. & Silverman, E (2010). Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med, 182(5), 605-13. eScholarID:98682 | PMID:20463177 | DOI:10.1164/rccm.200910-1586OC
• Hoogendoorn, M., Hoogenveen, R., Rutten-van Mölken, M., Vestbo, J. & Feenstra, T (2010). Case-fatality of COPD exacerbations: a meta-analysis and statistical modeling approach. Eur Respir J, eScholarID:98674 | PMID:20595157 | DOI:10.1183/09031936.00043710
• Hurst, J., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D., Agusti, A., Macnee, W., Calverley, P., Rennard, S., Wouters, E. & Wedzicha, J (2010). Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med, 363(12), 1128-38. eScholarID:98685 | PMID:20843247 | DOI:10.1056/NEJMoa0909883
• Hurst, J., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D., Agusti, A., Macnee, W., Calverley, P., Rennard, S., Wouters, E., Wedzicha, J. & . (2010). Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med, 363(12), 1128-38. eScholarID:137988 | PMID:20843247 | DOI:10.1056/NEJMoa0909883
• Ingebrigtsen, T., Thomsen, S., Vestbo, J., van der Sluis, S., Kyvik, K., Silverman, E., Svartengren, M. & Backer, V (2010). Genetic influences on Chronic Obstructive Pulmonary Disease - a twin study. Respir Med, 104(12), 1890-5. eScholarID:98681 | PMID:20541380 | DOI:10.1016/j.rmed.2010.05.004
• Iversen, K., Kjaergaard, J., Akkan, D., Kober, L., Torp-Pedersen, C., Hassager, C., Vestbo, J. & Kjoller, E (2010). The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail, 12(7), 685-91. eScholarID:98686 | PMID:20395261 | DOI:10.1093/eurjhf/hfq050
• Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E. (2010). Aortic Augmentation Index: Reference values in a large unselected population by means of the SphygmoCor device. American Journal of Hypertension, 23, 180-185. eScholarID:78082 | DOI:10.1038/ajh.2009.234
• Kerstjens, H., Bjermer, L., Eriksson, L., Dahlström, K. & Vestbo, J (2010). Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients. Respir Med, 104(9), 1297-303. eScholarID:98687 | PMID:20466530 | DOI:10.1016/j.rmed.2010.04.010
• Lange, P., Mogelvang, R., Marott, J., Vestbo, J. & Jensen, J (2010). Cardiovascular morbidity in COPD: A study of the general population. COPD, 7(1), 5-10. eScholarID:98672 | PMID:20214458 | DOI:10.3109/15412550903499506
• Sørheim, I., Bakke, P., Gulsvik, A., Pillai, S., Johannessen, A., Gaarder, P., Campbell, E., Agustí, A., Calverley, P., Donner, C., Make, B., Rennard, S., Vestbo, J., Wouters, E., Paré, P., Levy, R., Coxson, H., Lomas, D., Hersh, C. & Silverman, E (2010). α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest, 138(5), 1125-32. eScholarID:137993 | PMID:20595457 | DOI:10.1378/chest.10-0746
• Sørheim, I., Bakke, P., Gulsvik, A., Pillai, S., Johannessen, A., Gaarder, P., Campbell, E., Agustí, A., Calverley, P., Donner, C., Make, B., Rennard, S., Vestbo, J., Wouters, E., Paré, P., Levy, R., Coxson, H., Lomas, D., Hersh, C. & Silverman, E (2010). α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest, 138(5), 1125-32. eScholarID:98688 | PMID:20595457 | DOI:10.1378/chest.10-0746
• Spruit, M., Watkins, M., Edwards, L., Vestbo, J., Calverley, P., Pinto-Plata, V., Celli, B., Tal-Singer, R. & Wouters, E (2010). Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med, 104(6), 849-57. eScholarID:98679 | PMID:20471236 | DOI:10.1016/j.rmed.2009.12.007
• Vestbo J, Rennard SI. (2010). Chronic obstructive pulmonary disease biomarker(s) for disease activity needed - urgently. American Journal of Respiratory and Critical Care Medicine, 182(7), 863-864. eScholarID:98689 | DOI:10.1164/rccm.201004-0602ED
• Vestbo, J., Vogelmeier, C., Creemers, J., Falques, M., Ribera, A. & Gil, E (2010). Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD. COPD, 7(5), 331-6. eScholarID:98683 | PMID:20854047 | DOI:10.3109/15412555.2010.510158

2009

• 141. Jenkins CR, Jones PW, Calverley PMA, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J. (2009). Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study. Respiratory Research, 10, 59. eScholarID:141535
• Al-Shair K, Dockry R, Mallia-Milanes B, Kolsum UU, Singh SD, Vestbo J. (2009). Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med, 103, 1572-1579. eScholarID:1d19582 | DOI:10.1016/j.rmed.2008.11.021
• Al-shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D, Vestbo J. (2009). Development, dimensions, reliability and validity of the novel Machester COPD fatigue scale. Thorax, 64, 950-955. eScholarID:78079 | DOI:10.1136/thx.2009.118109
• Borrill Z, Roy K, Kolsum U, Southworth T, Vestbo J, Singh D. (2009). Seretide withdrawal increases airway inflammation in moderate COPD patients. European Journal of Clinical Pharmacology, 65, 1165-1166. eScholarID:78077 | DOI:10.1007/s00228-009-0697-5
• Camp, P, Coxson, H, Levy, R, Pillai, S, Anderson, W, Vestbo, J, Kennedy, S, Silverman, E, Lomas, D, Paré, P. (2009). Sex Differences in Emphysema and Airway Disease in Smokers. Chest, eScholarID:1d21354 | DOI:10.1378/chest.09-0676
• Crim, C, Calverley, P, Anderson, J, Celli, B, Ferguson, G, Jenkins, C, Jones, P, Willits, L, Yates, J, Vestbo, J. (2009). Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J, eScholarID:1d19585 | DOI:10.1183/09031936.00193908
• Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. (2009). Prevalence and Progression of Osteoporosis in Patients With COPD. Results From TORCH. Chest, eScholarID:1d21352 | DOI:10.1378/chest.08-3016
• Jenkins C, Jones P, Calverley P, Celli B, Anderson J, Ferguson G, Yates J, Willits L, Vestbo J. (2009). Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res, 10, eScholarID:1d21351 | DOI:10.1186/1465-9921-10-59
• Keene ON, Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, Jones PW. (2009). Methods for therapeutic trials in COPD: Lessons from the TORCH trial. European Respiratory Journal, 34, 1018-1023. eScholarID:78080 | DOI:10.1183/09031936.00122608
• Keene, O, Celli, B, Anderson, J, Ferguson, G, Jenkins, C, Jones, P, Vestbo, J, Knobil, K, Yates, J, Calverley, P. (2009). Lung function decline in COPD trials. Eur Respir J, 33( 3), 708-9; author reply 709-10. eScholarID:1d19597 | DOI:10.1183/09031936.00169908
• Kolsum UU, Borrill Z, Roy K, Starkey C, Vestbo J, Houghton C, Singh SD. (2009). Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med, 103( 1), 136-43. eScholarID:1d19610 | DOI:10.1016/j.rmed.2008.07.014
• Kolsum UU, Roy K, Starkey C, Borrill Z, Truman N, Vestbo J, Singh SD. (2009). The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis, 4( 1), 149-56. eScholarID:1d19587
• Miller M, Pedersen O, Lange P, Vestbo J. (2009). Improved survival prediction from lung function data in a large population sample. Respir Med, 103( 3), 442-8. eScholarID:1d19602 | DOI:10.1016/j.rmed.2008.09.016
• Plumb JJ, Smyth LLJ, Adams HR, Vestbo J, Bentley AAM, Singh SD. (2009). Increased T regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J, eScholarID:1d19600 | DOI:10.1183/09031936.00100708
• Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins CR, Knobil K, Willits LR. (2009). Adherence to inhaled therapy, mortality, and hospital admission in COPD. Thorax, 64, 939-943. eScholarID:78078 | DOI:10.1136/thx.2009.113662
• Vestbo J, Tan L, Atkinson G, Ward J. (2009). A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD. Eur Respir J, 33( 5), 1039-44. eScholarID:1d19598 | DOI:10.1183/09031936.00068908

2008

• Benfield T, Lange P, Vestbo J. (2008). Chronic obstructive pulmonary disease stage and risk of hospitalization for infectious disease. Chest, eScholarID:1d32332
• Brasch-Andersen C, Møller M, Haagerup A, Vestbo J, Kruse T. (2008). Evidence for an asthma risk locus on chromosome Xp: a replication linkage study. Allergy, 63( 9), 1235-8. eScholarID:1d19614 | DOI:10.1111/j.1398-9995.2008.01699.x
• Celli, B, Thomas, N, Anderson, J, Ferguson, G, Jenkins, C, Jones, P, Vestbo, J, Knobil, K, Yates, J, Calverley, P. (2008). Effect of Pharmacotherapy on Rate of Decline of Lung Function in COPD: Results from the TORCH Study. Am J Respir Crit Care Med, eScholarID:1d32031 | DOI:10.1164/rccm.200712-1869OC
• Godtfredsen N, Lam T, Hansel T, Leon M, Gray N, Dresler C, Burns D, Prescott E, Vestbo J. (2008). COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J, 32( 4), 844-53. eScholarID:1d19604 | DOI:10.1183/09031936.00160007
• Ingebrigtsen T, Thomsen S, Vestbo J, Backer V. (2008). [Chronic obstructive pulmonary disease and genetics]. Ugeskr Laeger, 170( 38), 2971-3. eScholarID:1d19605
• Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E. (2008). Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med, eScholarID:1d31924
• Keene O, Calverley P, Jones P, Vestbo J, Anderson J. (2008). Statistical analysis of COPD exacerbations. Eur Respir J, 32( 5), 1421-2. eScholarID:1d19603 | DOI:10.1183/09031936.00123408
• Kirkham SS, Kolsum UU, Rousseau K, Singh SD, Vestbo J, Thornton DD.J. (2008). MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 178( 10), 1033-9. eScholarID:1d19608 | DOI:10.1164/rccm.200803-391OC
• Møller-Larsen S, Nyegaard M, Haagerup A, Vestbo J, Kruse T, Børglum A. (2008). Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax, 63( 12), 1064-9. eScholarID:1d19615 | DOI:10.1136/thx.2007.094128
• Patel, B, Coxson, H, Pillai, S, Agusti, A, Calverley, P, Donner, C, Make, B, Muller, N, Rennard, S, Vestbo, J, Wouters, E, Hiorns, M, Nakano, Y, Camp, P, Nasute Fauerbach, P, Screaton, N, Campbell, E, Anderson, W, Silverman, E, Lomas, D. (2008). Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in COPD. Am J Respir Crit Care Med, eScholarID:1d32279 | DOI:10.1164/rccm.200801-059OC
• Rennard S, Vestbo J. (2008). Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 5( 9), 878-83. eScholarID:1d19601 | DOI:10.1513/pats.200804-035QC
• Rennard S, Vestbo J. (2008). The many "small COPDs": COPD should be an orphan disease. Chest, 134( 3), 623-7. eScholarID:1d19606 | DOI:10.1378/chest.07-3059
• Smyth LLJ, Starkey C, Gordon F, Vestbo J, Singh SD. (2008). CD8 chemokine receptors in chronic obstructive pulmonary disease. Clin Exp Immunol, 154( 1), 56-63. eScholarID:1d19613 | DOI:10.1111/j.1365-2249.2008.03729.x
• Vestbo J. (2008). COPD, diagrams and traditions: time to move on? Thorax, 63( 9), 755-6. eScholarID:1d19611 | DOI:10.1136/thx.2007.092924
• Vestbo, J, Anderson, W, Coxson, H, Crim, C, Dawber, F, Edwards, L, Hagan, G, Knobil, K, Lomas, D, MacNee, W, Silverman, E, Tal-Singer, R, NULL. (2008). Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J, 31( 4), 869-73. eScholarID:1d31925 | DOI:10.1183/09031936.00111707
• White, J, Chiano, M, Wigglesworth, M, Geske, R, Riley, J, White, N, Hall, S, Zhu, G, Maurio, F, Savage, T, Anderson, W, Cordy, J, Ducceschi, M, NULL, Vestbo, J, Pillai, S. (2008). Identification of a novel asthma susceptibility gene on chromosome 1qter and its functional evaluation. Hum Mol Genet, 17( 13), 1890-903. eScholarID:1d32037 | DOI:10.1093/hmg/ddn087
• Zhu G, Whyte MK, Vestbo J, Carlsen K, Carlsen KH, Lenney W, Silverman M, Helms P, Pillai SG. (2008). Interleukin 18 receptor 1 gene polymorphisms are associated with asthma. Eur J Hum Genet, eScholarID:1d32333

2007

• Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P, Yates J, Vestbo J. (2007). Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 356( 8), 775-89. eScholarID:1d15591 | DOI:10.1056/NEJMoa063070
• Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. (2007). Salmeterol/Fluticasone propionate and survival in chronic obstructive pulmonary disease:the TORCH trail. N Engl J Med, eScholarID:1d14591
• Corydon T, Haagerup A, Jensen T, Binderup H, Petersen M, Kaltoft K, Vestbo J, Kruse T, Børglum A. (2007). A functional CD86 polymorphism associated with asthma and related allergic disorders. J Med Genet, 44( 8), 509-15. eScholarID:1d32108
• Løkke A, Fabricius P, Vestbo J, Marott J, Lange P. (2007). [Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study]. Ugeskr Laeger, 169( 46), 3956-60. eScholarID:1d32280
• Roy K, Borrill Z, Starkey C, Hazel A, Morris J, Vestbo J, Singh SD. (2007). Use of different exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J, 29( 4), 651-9. eScholarID:1d31432
• Smyth L, Starkey C, Vestbo J, Singh SD. (2007). CD4-regulatory cells in COPD patients. Chest, 132( 1), 156-63. eScholarID:1d31384
• Soriano, J, Sin, D, Zhang, X, Camp, P, Anderson, J, Anthonisen, N, Buist, A, Burge, P, Calverley, P, Connett, J, Petersson, S, Postma, D, Szafranski, W, Vestbo, J. (2007). A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest, 131( 3), 682-9. eScholarID:1d31413
• Vestbo J. (2007). [Salmeterol and fluticason and mortality in COPD patients]. Ugeskr Laeger, 169( 38), 3198-201. eScholarID:1d31824
• Vestbo J. (2007). Chronic cough and phlegm in young adults: should we worry? Am J Respir Crit Care Med, 175( 1), 2-3. eScholarID:1d30496
• Vestbo J. (2007). COPD: who has it, who hasn't--and then what ? COPD, 4( 4), 303-4. eScholarID:1d31926
• Vestbo J. (2007). Systemic inflammation and progression of COPD. Thorax, 62( 6), 469-70. eScholarID:1d31877
• Zhu G, Vestbo J, Lenney W, Silverman M, Whyte M, Helms P, Anderson W, Pillai S. (2007). Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun, 8( 5), 398-403. eScholarID:1d31927

2006

• Brasch-Andersen C, Haagerup A, Børglum A, Vestbo J, Kruse T. (2006). Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases. J Med Genet, 43(3), eScholarID:1d30859
• Brasch-Andersen C, Tan Q, Børglum A, Haagerup A, Larsen T, Vestbo J, Kruse T. (2006). Significant linkage to chromosome 12q24.32-q24.33 and identification of SFRS8 as a possible asthma susceptibility gene. Thorax, 61( 10), 874-9. eScholarID:1d30522
• Celli B, Cross S, Grossman R, Kardos P, Myrseth S, Rodriguez-Roisin R, Vestbo J. (2006). Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD. Prim Care Respir J, 15( 3), 139-42. eScholarID:1d30582
• Christensen U, Haagerup A, Binderup H, Vestbo J, Kruse T, Børglum A. (2006). Family based association analysis of the IL2 and IL15 genes in allergic disorders. Eur J Hum Genet, 14( 2), 227-35. eScholarID:1d30457
• Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. (2006). C-reactive Protein as a Predictor of Prognosis in COPD. Am J Respir Crit Care Med, eScholarID:1d31539
• Fabricius P, Scharling H, Løkke A, Vestbo J, Lange P. (2006). Exhaled CO, a predictor of lung function? Respir Med, eScholarID:1d30581
• Godtfredsen N, Prescott E, Vestbo J, Osler M. (2006). Smoking reduction and biomarkers in two longitudinal studies. Addiction, 101( 10), 1516-22. eScholarID:1d30504
• Jensen H, Godtfredsen N, Lange P, Vestbo J. (2006). Potential misclassification of causes of death from COPD. Eur Respir J, 28( 4), 781-5. eScholarID:1d30475
• Lange P, Scharling H, Ulrik C, Vestbo J. (2006). Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax, 61( 2), 100-4. eScholarID:1d30860
• Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. (2006). Developing COPD: a 25 year follow up study of the general population. Thorax, 61( 11), 935-9. eScholarID:1d30474
• Løkke A, Lange P, Vestbo J, Fabricius P. (2006). Developing COPD--25 years follow-up study of the general population. Ugeskr Laeger, 168(50), 4422-4424. eScholarID:1d31659
• Mannino, D, Watt, G, Hole, D, Gillis, C, Hart, C, McConnachie, A, Davey Smith, G, Upton, M, Hawthorne, V, Sin, D, Man, S, Van Eeden, S, Mapel, D, Vestbo, J. (2006). The natural history of chronic obstructive pulmonary disease. Eur Respir J, 27( 3), 627-43. eScholarID:1d31540
• Rennard S, Vestbo J. (2006). COPD: the dangerous underestimate of 15%. Lancet, 367( 9518), 1216-9. eScholarID:1d30539
• Vestbo J, Hogg J. (2006). Convergence of the epidemiology and pathology of COPD. Thorax, 61( 1), 86-8. eScholarID:1d30579
• Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard B, Andersen T, Sørensen T, Lange P. (2006). Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med, 173( 1), 79-83. eScholarID:1d14434 | DOI:10.1164/rccm.200505-969OC
• Vestbo J. (2006). Clinical assessment, staging, and epidemiology of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc, 3( 3), 252-6. eScholarID:1d30523
• Webb, B, van den Oord, E, Akkari, A, Wilton, S, Ly, T, Duff, R, Barnes, K, Carlsen, K, Gerritsen, J, Lenney, W, Silverman, M, Sly, P, Sundy, J, Tsanakas, J, von Berg, A, Whyte, M, Blumenthal, M, Vestbo, J, Middleton, L, Helms, P, Anderson, W, Pillai, S. (2006). Quantitative linkage genome scan for atopy in a large collection of Caucasian families. Hum Genet, eScholarID:1d30858

2005

• Borrill Z, Houghton C, Woodcock AA, Vestbo J, Singh SD. (2005). Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol, 59( 4), 379-84. eScholarID:1d30706
• Borrill Z, Starkey C, Vestbo J, Singh Dave. (2005). Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J, 25( 2), 269-74. eScholarID:1d29437
• Borrill Z, Starkey C, Vestbo J, Singh SD. (2005). Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. European Respiratory Journal, 25, 269-274. eScholarID:1d26706 | DOI:10.1183/09031936.05.00085804
• Decramer, M, Gosselink, R, Bartsch, P, Löfdahl, C, Vincken, W, Dekhuijzen, R, Vestbo, J, Pauwels, R, Naeije, R, Troosters, T. (2005). Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax, 60( 4), 343-9. eScholarID:1d28841
• Hansen E, Vestbo J. (2005). Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness? Eur Respir J, 26( 1), 6-7. eScholarID:1d29676
• Juul K, Tybjærg-Hansen A, Mortensen J, Lange P, Vestbo J, Nordestgaard BG. (2005). Factor V Leiden Homozygosity, Dyspnea, and Reduced Pulmonary Function. Arch Intern Med, 165( 17), 2032-2036. eScholarID:1d28885
• Kiri V, Pride N, Soriano J, Vestbo J. (2005). Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med, 172( 4), 460-4. eScholarID:1d30705
• Peabody J, Schau B, Lopez-Vidriero M, Vestbo J, Wade S, Iqbal A. (2005). COPD: a prevalence estimation model. Respirology, 10( 5), 594-602. eScholarID:1d30578
• Pisinger C, Vestbo J, Borch-Johnsen K, Jørgensen T. (2005). It is possible to help smokers in early motivational stages to quit. The Inter99 study. Prev Med, 40( 3), 278-84. eScholarID:1d29752
• Pisinger C, Vestbo J, Borch-Johnsen K, Jørgensen T. (2005). Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Prev Med, 40( 3), 285-92. eScholarID:1d30707
• Pisinger C, Vestbo J, Borch-Johnsen K, Jørgensen T. (2005). Smoking reduction intervention in a large population-based study. The Inter99 study. Prev Med, 40( 1), 112-8. eScholarID:1d30708
• Pisinger C, Vestbo J, Borch-Johnsen K, Thomsen T, Jørgensen T. (2005). Acceptance of the smoking cessation intervention in a large population-based study: the Inter99 study. Scand J Public Health, 33( 2), 138-45. eScholarID:1d29582
• Sin, D, Wu, L, Anderson, J, Anthonisen, N, Buist, A, Burge, P, Calverley, P, Connett, J, Lindmark, B, Pauwels, R, Postma, D, Soriano, J, Szafranski, W, Vestbo, J. (2005). Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax, 60( 12), 992-7. eScholarID:1d31541
• Vestbo J, Pauwels R, Anderson J, Jones P, Calverley P. (2005). Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Thorax, 60( 4), 301-4. eScholarID:1d29436
• Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. (2005). Body Mass, Fat Free Body Mass and Prognosis in COPD Patients from a Random Population Sample. Am J Respir Crit Care Med, eScholarID:1d29600
• Vestbo J. (2005). Chronic mucus hypersecretion, exacerbations and natural history of COPD. Exp Lung Res, 31 Suppl 1, 63-5. eScholarID:1d30456

2004

• Brasch-Andersen C, Christiansen L, Tan Q, Haagerup A, Vestbo J, Kruse T. (2004). Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum Mutat, 24( 3), 208-14. eScholarID:1d29403
• Grønbaek M, Johansen D, Becker U, Hein H, Schnohr P, Jensen G, Vestbo J, Sørensen T. (2004). Changes in alcohol intake and mortality: a longitudinal population-based study. Epidemiology, 15( 2), 222-8. eScholarID:1d28887
• Kiri V, Vestbo J, Pride N, Soriano J. (2004). Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J, 24( 1), 190-1; author reply 191-2. eScholarID:1d28886
• Pillai, S, Cousens, D, Barnes, A, Buckley, P, Chiano, M, Hosking, L, Cameron, L, Fling, M, Foley, J, Green, A, Sarau, H, Schmidt, D, Sprankle, C, Blumenthal, M, Vestbo, J, Kennedy-Wilson, K, Wixted, W, Wagner, M, Anderson, W, Ignar, D, NULL. (2004). A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma. Pharmacogenetics, 14( 9), 627-33. eScholarID:1d29601
• Vestbo J, Soriano J, Anderson J, Calverley P, Pauwels R, Jones P. (2004). Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med, 98( 11), 1045-50. eScholarID:1d29677
• Vestbo J. (2004). Chronic bronchitis: should it worry us? Chron Respir Dis, 1( 3), 173-6. eScholarID:1d30471
• Vestbo J. (2004). Outpatient management of chronic obstructive pulmonary disease. Clin Med, 4( 3), 220-4. eScholarID:1d29602
• Vestbo J. (2004). The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J, 24( 2), 206-10. eScholarID:1d29152
• Watson L, Vestbo J, Postma D, Decramer M, Rennard S, Kiri V, Vermeire P, Soriano J. (2004). Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med, 98( 12), 1207-13. eScholarID:1d28842

2003

• Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. (2003). Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 361( 9356), 449-56. eScholarID:1d6768 | DOI:10.1016/S0140-6736(03)12459-2

2002

• Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard B. (2002). Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med, 136( 4), 270-9. eScholarID:1d28516
• Godtfredsen N, Holst C, Prescott E, Vestbo J, Osler M. (2002). Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. Am J Epidemiol, 156( 11), 994-1001. eScholarID:1d28482
• Rennard S, Decramer M, Calverley P, Pride N, Soriano J, Vermeire P, Vestbo J. (2002). Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J, 20( 4), 799-805. eScholarID:1d28483
• Vestbo J, Lange P. (2002). Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med, 166( 3), 329-32. eScholarID:1d6769 | DOI:10.1164/rccm.2112048

2001

• Hansen E, Vestbo J, Phanareth K, Kok-Jensen A, Dirksen A. (2001). Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 163( 3 Pt 1), 690-3. eScholarID:1d28448